- Home
- CDT vs WNW Comparison
CDT vs WNW Comparison
Compare CDT & WNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CDT
- WNW
- Stock Information
- Founded
- CDT 2019
- WNW 2015
- Country
- CDT United States
- WNW China
- Employees
- CDT N/A
- WNW N/A
- Industry
- CDT Biotechnology: Pharmaceutical Preparations
- WNW Catalog/Specialty Distribution
- Sector
- CDT Health Care
- WNW Consumer Discretionary
- Exchange
- CDT Nasdaq
- WNW Nasdaq
- Market Cap
- CDT 5.2M
- WNW 4.4M
- IPO Year
- CDT N/A
- WNW 2020
- Fundamental
- Price
- CDT $0.54
- WNW $1.97
- Analyst Decision
- CDT
- WNW
- Analyst Count
- CDT 0
- WNW 0
- Target Price
- CDT N/A
- WNW N/A
- AVG Volume (30 Days)
- CDT 7.4M
- WNW 6.6M
- Earning Date
- CDT 05-13-2025
- WNW 11-15-2024
- Dividend Yield
- CDT N/A
- WNW N/A
- EPS Growth
- CDT N/A
- WNW N/A
- EPS
- CDT N/A
- WNW N/A
- Revenue
- CDT N/A
- WNW $380,345.00
- Revenue This Year
- CDT N/A
- WNW N/A
- Revenue Next Year
- CDT N/A
- WNW N/A
- P/E Ratio
- CDT N/A
- WNW N/A
- Revenue Growth
- CDT N/A
- WNW N/A
- 52 Week Low
- CDT $0.51
- WNW $0.95
- 52 Week High
- CDT $350.00
- WNW $70.00
- Technical
- Relative Strength Index (RSI)
- CDT 36.40
- WNW 46.03
- Support Level
- CDT $0.52
- WNW $0.95
- Resistance Level
- CDT $1.01
- WNW $2.95
- Average True Range (ATR)
- CDT 0.16
- WNW 0.30
- MACD
- CDT 0.02
- WNW 0.22
- Stochastic Oscillator
- CDT 3.43
- WNW 51.00
About CDT Conduit Pharmaceuticals Inc.
Conduit Pharmaceuticals Inc is a clinical-stage specialty biopharmaceutical company that was formed to facilitate the development and commercialization of clinical assets that have not been or are not being, prioritized by biopharmaceutical companies to develop pharmaceutical products that meet the unmet medical needs of patients. The Company's current development pipeline includes a glucokinase activator, which is Phase II ready for autoimmune diseases including uveitis, Hashimoto's Thyroiditis, preterm labor, and renal transplant rejection. The Company's development pipeline also includes a potent, irreversible inhibitor of human Myeloperoxidase (MPO) that has the potential to treat idiopathic male infertility.
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments: Clean Food Platform; Restaurant; and Others. The company generates the majority of its revenue from Technical services.